|Day Low/High||18.52 / 18.92|
|52 Wk Low/High||17.04 / 32.90|
Investors in Intrexon Corp saw new options become available this week, for the April 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
RIVM concludes negligible risk of Oxitec's Friendly™ Aedes mosquitoes
A roundup of Cramer's comments on stocks of interest to viewers.
With the Fed and the healthcare vote out of the way, markets will focus on earnings in the week ahead.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
-- Study Results Further Support Advancement of SYN-005 into Clinical Trials for Treatment and Prevention of Pertussis --
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.
Jim Cramer says Pfizer needs to do a deal and buy someone; and he thinks Raytheon is a terrific stock.
Doug Kass shares his thoughts on Twitter and talks about Sears.
Geno Germano to Step Down as President; Randal Kirk to Remain CEO
Saudi Aramco will assume control of the biggest oil refinery in the U.S. after a $2.2 billion deal with Shell that exits a joint venture in Port Arthur, Texas.
The most recent short interest data was recently released for the 01/31/2017 settlement date, and Intrexon Corp is one of the most shorted stocks of the Russell 3000, based on 11.99 "days to cover" versus the median component at 5.13. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.